DEUTSCHE BANK AG\ - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 69 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$169,000
-4.5%
34,956
+108.2%
0.00%
Q4 2019$177,000
+32.1%
16,793
+29.4%
0.00%
Q3 2019$134,000
-36.8%
12,978
-7.1%
0.00%
Q2 2019$212,000
+39.5%
13,965
+17.6%
0.00%
Q1 2019$152,000
-1.3%
11,873
-27.1%
0.00%
Q4 2018$154,000
-93.6%
16,297
-88.7%
0.00%
-100.0%
Q3 2018$2,396,000
-14.3%
144,450
-17.1%
0.00%0.0%
Q2 2018$2,795,000
+147.3%
174,208
+135.5%
0.00%0.0%
Q1 2018$1,130,000
+44.1%
73,979
+46.9%
0.00%0.0%
Q4 2017$784,000
-63.6%
50,349
-74.1%
0.00%0.0%
Q3 2017$2,153,000
+17.9%
194,146
-2.2%
0.00%0.0%
Q2 2017$1,826,000
+78.1%
198,610
+65.4%
0.00%0.0%
Q1 2017$1,025,000
-44.2%
120,050
-30.1%
0.00%0.0%
Q4 2016$1,837,000
+22.3%
171,848
+23.9%
0.00%0.0%
Q3 2016$1,502,000
+90.4%
138,748
+18.8%
0.00%0.0%
Q2 2016$789,000
+53.2%
116,761
+5.3%
0.00%
Q1 2016$515,000
+94.3%
110,871
+161.6%
0.00%
Q4 2015$265,000
+616.2%
42,387
+876.2%
0.00%
Q3 2015$37,000
-50.0%
4,342
-33.0%
0.00%
Q2 2015$74,000
+184.6%
6,482
+255.4%
0.00%
Q1 2015$26,000
-73.5%
1,824
-68.6%
0.00%
Q4 2014$98,000
+292.0%
5,807
+177.2%
0.00%
Q3 2014$25,000
+1150.0%
2,095
+696.6%
0.00%
Q2 2014$2,000
-98.6%
263
-96.2%
0.00%
Q1 2014$139,000
+36.3%
6,866
+31.4%
0.00%
Q4 2013$102,000
-81.4%
5,226
-56.9%
0.00%
Q3 2013$549,00012,1350.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders